Precigen Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 2.27
Ask Price 2.33
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Precigen Inc PGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.28 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 1.12 - 6.455
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.28 USD


Draw Mode:

Precigen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 474.58M 208.15M 121.05M $ 103.87M $ -97.54M -0.47 -5.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -213.66k 2.40%

more financials information »

Precigen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.482.64112.2652.411,189,774-0.20-8.06%
1 Month1.872.64111.512.061,198,7680.4121.93%
3 Months1.232.64111.17441.661,670,5881.0585.37%
6 Months2.032.64111.121.791,566,4260.2512.32%
1 Year5.936.4551.122.871,476,898-3.65-61.55%
3 Years5.1311.101.124.651,447,107-2.85-55.56%
5 Years5.1311.101.124.651,447,107-2.85-55.56%

Precigen Description

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals; Exemplar, and Trans Ova. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now